Supreme Court wants cap on trade margin for all essential medicines and medical products

AI Summary

India’s Supreme Court has questioned why a proposed 30% trade-margin cap for cancer medicines cannot be extended to all essential medicines and medical products. The court also stressed that the government must ensure patients can obtain medicines whose prices are regulated under the Drug Price Control Order.

Government proposes 30% trade-margin cap on patented and non-patented cancer medicines, but top court asks why a margin cap cannot be extended to all medicines and medical products; the court says the government has to ensure that DPCO-approved medicines, whose price is legally regulated, reach patients